Pediatric Acute Kidney Injury in COVID-19
Research Question:
What can we learn about COVID-19 in children by collecting health information from
children with COVID-19 infection who are admitted to intensive care?
Basic Study Information
Purpose:
This study is an observational registry of children with or suspected to have SARS
CoV2
(COVID-19) admitted to pediatric intensive care units (PICU). This registry will help
describe the prevalence, rate and severity of acute kidney injury (AKI) in children
with
Severe Acute Respiratory Syndrome Coronavirus-2(SARS CoV2) across the world. The registry
will be developed using a point prevalence methodology and then full retrospective
review.
Once a week, from April through June 2020, data collection will occur in "real-time"
to
estimate a weekly point prevalence of AKI and renal replacement therapy (RRT). The
operational definition of "patients under investigation" (PUIs) will be used to identify
the
denominator of patients to be studied. The PUIs will be cohorted into SARS CoV2 test
positive, test negative, test pending, or test unavailable. The primary aim of this
study is
to deliver a global, objective data driven analysis of the burden of AKI in virus
positive
patients or patients under investigation (PUI) who are admitted to the pediatric intensive
care unit.
Study Reference #: 4858
Lead Researcher (Principal Investigator)
Lead Researcher:
Susan Martin
Study Contact Information
Email: researchhelp@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search